The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis
about
Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonistsThe Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to MetforminQuantifying the Effect of Metformin Treatment and Dose on Glycemic ControlOverview of methods for comparing the efficacies of drugs in the absence of head-to-head clinical trial dataThe Glucose-lowering Efficacy of Sitagliptin in Obese Japanese Patients with Type 2 Diabetes.Participation in a farmers' market fruit and vegetable prescription program at a federally qualified health center improves hemoglobin A1C in low income uncontrolled diabetics.Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials.Opioid use disorder and type 2 diabetes mellitus: Effect of participation in buprenorphine-naloxone substitution programs on glycemic controlGlycemic control: a combination of lifestyle management and the use of drugsEffect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.Using simulation technology to teach diabetes care management skills to resident physiciansEfficacy and safety of sitagliptin in Japanese patients with type 2 diabetesThe role of bile acid sequestrants in the management of type 2 diabetes mellitusA review of the treatment of type 2 diabetes in childrenPredictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review.Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC StudyReaction time in adolescence, cumulative allostatic load, and symptoms of anxiety and depression in adulthood: the West of Scotland Twenty-07 Study.The importance of age, sex and place in understanding socioeconomic inequalities in allostatic load: Evidence from the Scottish Health Survey (2008-2011)Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients.Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations.A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.Are diabetes management guidelines applicable in 'real life'?Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis.Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38).Clinical characteristics of the responders to dipeptidyl peptidase-4 inhibitors in Korean subjects with type 2 diabetes.Clinical Outcomes of Continuation of Metformin Titration Instructions with Electronic Prescribing.Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS studyImpact of ATM and SLC22A1 Polymorphisms on Therapeutic Response to Metformin in Iranian Diabetic Patients.Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.Pharmacogenetics of oral antidiabetic drugs.Standards of care for type 2 diabetes in China.A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes.Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trialsVildagliptin in the treatment of type 2 diabetes mellitus.Initial combination with linagliptin and metformin in newly diagnosed type 2 diabetes and severe hyperglycemia.Evolving therapeutic options for type 2 diabetes mellitus: an overview.Risk vs benefit in diabetes pharmacotherapy: a rational approach to choosing pharmacotherapy in type 2 diabetes.Review of insulin-dependent and insulin-independent agents for treating patients with type 2 diabetes mellitus and potential role for sodium-glucose co-transporter 2 inhibitors.The long-term efficacy and safety of DPP-IV inhibitors monotherapy and in combination with metformin in 18,980 patients with type-2 diabetes mellitus--a meta-analysis.Type 2 diabetes pharmacoepidemiology update 2014: safety versus efficacy.
P2860
Q28077026-49C4A013-B8A6-4ABD-9972-0ACA13DDA345Q28550746-BA3B1E3E-561C-46E1-A140-CB5324BD339EQ29038351-3FA5EBEE-D54D-432F-B459-D087581C8011Q30619855-B0D199FA-C2F6-4C48-8831-14D028DB9A73Q33619167-0EE7DD38-FB20-4F43-B0C7-D09888193A30Q33868531-986E5CD9-DA99-4AAC-9199-E57F21073B08Q33871459-E7DC0819-F38A-44C6-9868-B99D3EC4977FQ33897658-3C530A53-99F4-43A7-A6AB-237FB288F168Q33936137-B9F45110-6AF5-4B18-A6C8-CB52DC308EA1Q34988073-65ADBBA3-7433-45E3-9C85-1D0CFE4573A8Q35017252-C191B958-D4B6-486F-BFF5-7F773A2529DDQ35087917-BF615746-6BCB-48EE-9EBF-3759D5574C2BQ35104031-3173A502-9DE6-4605-96F8-9D1BC9511300Q35157954-8BBF3E10-3A49-4E82-99C3-A63309F0C80DQ35541829-248EBD3B-1017-4CAB-8FF1-52D5786563B6Q35661969-68CA3FA9-7248-4C46-80A6-09C85EE5CE11Q35695745-368AA461-08F2-4E68-A9D1-A3EAB7387251Q35917600-295B7E00-F21C-4B7F-A6B9-962603496F9BQ36144000-F8C4DE46-0152-4113-8AAD-867DD0E7D0A7Q36333089-0525A1DD-178E-4F37-BD25-88FCF61A6C4EQ36349300-A11D6D29-60B8-47F6-85F0-A41434EED195Q36541839-A2EC7B68-0598-4534-953B-7D2C3383CE1CQ36755942-73ED1A11-00AD-43FE-991D-4F8DFEBB10ECQ36843917-AA66F083-CDB2-4001-AC25-354814CEE71CQ36917168-B81B56DC-FBF9-4877-836F-B3874E0D53A5Q36942830-1362E206-97D6-417D-BD7E-8B55FD6B9D6FQ36952295-13896162-F08C-4F29-8C75-F5A4D3331456Q37028124-BF5E524A-2CE8-47DB-A32C-859216891A7EQ37222650-66DDB2A2-8F03-44E0-90D0-632E82BB33A8Q37353476-CC66CF2F-6D95-4AEB-BC6F-2971F14C43DFQ37412792-70EFAA24-EB80-4479-B5C2-C70862A47AA3Q37596997-6ECDCD3C-F11E-4783-AC2A-B58A13F2107CQ37677470-1ED27350-0DAA-4532-A363-FE5774F9B141Q37890411-58CEBA58-0F31-4DE3-8E73-4CC829A4E99CQ38065105-6ACE876C-D060-486E-B235-3BE291634CA0Q38074336-FED777A7-646C-4CEB-AEB3-C5A282C28DDAQ38091380-B3BD415B-7666-4253-9DDE-254AB98E806AQ38113101-8F77BB28-E72E-4D7B-9A4B-62C9FF23896EQ38196747-9E709305-7693-4B2D-A08E-8C64D3D71C57Q38264376-581CA861-A902-4C85-AA47-11F85A2D68A4
P2860
The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The effect of oral antidiabeti ...... matic review and meta-analysis
@ast
The effect of oral antidiabeti ...... matic review and meta-analysis
@en
The effect of oral antidiabeti ...... matic review and meta-analysis
@nl
type
label
The effect of oral antidiabeti ...... matic review and meta-analysis
@ast
The effect of oral antidiabeti ...... matic review and meta-analysis
@en
The effect of oral antidiabeti ...... matic review and meta-analysis
@nl
prefLabel
The effect of oral antidiabeti ...... matic review and meta-analysis
@ast
The effect of oral antidiabeti ...... matic review and meta-analysis
@en
The effect of oral antidiabeti ...... matic review and meta-analysis
@nl
P2093
P2860
P31
P921
P356
P1433
P1476
The effect of oral antidiabeti ...... matic review and meta-analysis
@en
P2093
Diana Sherifali
Eleanor Pullenayegum
Ji Emmy Cheng
Kara Nerenberg
P2860
P304
P356
10.2337/DC09-1727
P407
P577
2010-05-18T00:00:00Z
2010-08-01T00:00:00Z